Westfield Capital Management
CCXI

Westfield Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Westfield Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,102,332
Closed -$8.93M – 302
2015
Q4 		$8.93M Buy
1,102,332
+19,375
+2% +$137K 0.06% 202
2015
Q3 		$6.55M Sell
1,082,957
-41,440
-4% -$300K 0.05% 198
2015
Q2 		$9.25M Sell
1,124,397
-147,701
-12% -$1.17M 0.06% 213
2015
Q1 		$9.6M Sell
1,272,098
-4,735
-0.4% -$37K 0.06% 234
2014
Q4 		$8.72M Sell
1,276,833
-89,960
-7% -$476K 0.05% 238
2014
Q3 		$6.15M Sell
1,366,793
-34,200
-2% -$181K 0.04% 234
2014
Q2 		$8.2M Sell
1,400,993
-1,310
-0.1% -$7.35K 0.05% 233
2014
Q1 		$9.3M Buy
+1,402,303
New +$9.74M 0.06% 235
2013
Q3 		– Sell
-21,700
Closed -$307K – 378
2013
Q2 		$307K Buy
+21,700
New +$281K ﹤0.01% 332

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Westfield Capital Management's CCXI Position: Q1 2016 in Review

Westfield Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2016, closing a stake of 1,102,332 shares — an estimated $8.93M sold.

Westfield Capital Management first reported a position in CCXI in Q2 2013 and held it in 9 quarters. The position peaked at $9.6M in Q1 2015. 71 funds tracked by Wall St. Rank hold CCXI as of Q1 2016.

  • Westfield Capital Management reported no remaining ChemoCentryx, Inc. position as of Q1 2016 after selling out during the quarter.
  • Westfield Capital Management sold 1,102,332 ChemoCentryx, Inc. shares in Q1 2016, an estimated $8.93M.
  • Westfield Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 9 quarters.
  • Westfield Capital Management's ChemoCentryx, Inc. position peaked at $9.6M in Q1 2015.
  • 71 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2016.

Based on Westfield Capital Management's 13F filing for Q1 2016, filed 13 May 2016.